ADVM logo

Adverum Biotechnologies (ADVM) Company Overview

Profile

Full Name:

Adverum Biotechnologies, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 31, 2014

Indexes:

Not included

Description:

Adverum Biotechnologies is a biotechnology company focused on developing gene therapies for eye diseases and other serious conditions. They aim to create innovative treatments that can improve patients' lives by targeting the underlying causes of diseases using advanced genetic technology.

Events Calendar

Earnings

Next earnings date:

Mar 18, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Mar 18, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 21, 2024

Analyst ratings

Recent major analysts updates

Nov 19, 24 HC Wainwright & Co.
Buy
Nov 5, 24 RBC Capital
Sector Perform
Aug 14, 24 Truist Securities
Buy
Aug 13, 24 RBC Capital
Sector Perform
Aug 13, 24 HC Wainwright& Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Jul 18, 24 Chardan Capital
Buy
Jun 25, 24 Oppenheimer
Outperform
May 15, 24 Truist Securities
Buy
May 10, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Adverum Biotechnologies?
  • Does Adverum Biotechnologies pay dividends?
  • What sector is Adverum Biotechnologies in?
  • What industry is Adverum Biotechnologies in?
  • What country is Adverum Biotechnologies based in?
  • When did Adverum Biotechnologies go public?
  • Is Adverum Biotechnologies in the S&P 500?
  • Is Adverum Biotechnologies in the NASDAQ 100?
  • Is Adverum Biotechnologies in the Dow Jones?
  • When was Adverum Biotechnologies's last earnings report?
  • When does Adverum Biotechnologies report earnings?
  • Should I buy Adverum Biotechnologies stock now?

What is the ticker symbol for Adverum Biotechnologies?

The ticker symbol for Adverum Biotechnologies is NASDAQ:ADVM

Does Adverum Biotechnologies pay dividends?

No, Adverum Biotechnologies does not pay dividends

What sector is Adverum Biotechnologies in?

Adverum Biotechnologies is in the Healthcare sector

What industry is Adverum Biotechnologies in?

Adverum Biotechnologies is in the Biotechnology industry

What country is Adverum Biotechnologies based in?

Adverum Biotechnologies is headquartered in United States

When did Adverum Biotechnologies go public?

Adverum Biotechnologies's initial public offering (IPO) was on July 31, 2014

Is Adverum Biotechnologies in the S&P 500?

No, Adverum Biotechnologies is not included in the S&P 500 index

Is Adverum Biotechnologies in the NASDAQ 100?

No, Adverum Biotechnologies is not included in the NASDAQ 100 index

Is Adverum Biotechnologies in the Dow Jones?

No, Adverum Biotechnologies is not included in the Dow Jones index

When was Adverum Biotechnologies's last earnings report?

Adverum Biotechnologies's most recent earnings report was on Nov 4, 2024

When does Adverum Biotechnologies report earnings?

The next expected earnings date for Adverum Biotechnologies is Mar 18, 2025

Should I buy Adverum Biotechnologies stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions